MD HB420

Replaces the term "auto-injectable epinephrine" with "emergency use epinephrine" throughout Maryland law to include any FDA-approved portable drug delivery device or product containing a premeasured single dose of epinephrine for treating anaphylaxis

Renames the Emergency Use Auto-Injectable Epinephrine Program to the Emergency Use Epinephrine Program

Applies the updated terminology across multiple settings including public schools, nonpublic schools, child care providers, youth camps, food service facilities, recreation and wellness facilities at higher education institutions, and naturopathic medicine practice

Maintains existing authorization for trained personnel to administer emergency epinephrine to individuals experiencing or believed to be experiencing anaphylaxis, with civil liability protections for good-faith administration

Effective date: June 1, 2025